肺癌治療路徑：前導性化療、免疫治療與後續開刀，還要繼續免疫治療嗎？ Lung Cancer Treatment Pathway

在肺癌的治療過程中，前導性化療與免疫治療後進行手術，患者是否需要繼續接受免疫治療是一個常見的臨床問題。本影片將介紹臨床試驗中對於哪些病患需要在手術後繼續免疫治療的最新發現，並分析這些治療策略對於不同階段肺癌病患的預後影響，幫助病患和家屬了解後續治療的重要性。


In the treatment of lung cancer, a common clinical question arises after neoadjuvant chemotherapy, immunotherapy, and surgery: should patients continue immunotherapy? This video will explore the latest findings from clinical trials on who benefits from continued immunotherapy post-surgery and analyze how these treatment strategies impact the prognosis for lung cancer patients at different stages. This video aims to help patients and families understand the importance of post-operative treatment.